Byoung Goo Min
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Byoung Goo Min has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Wook Eun Kim
Interdisciplinary Program in Medical and Biological Engineering, Seoul National University
3 shared publicationsCho Hae Mun
Interdisciplinary Program in Biomedical Engineering Major, Seoul National University
2 shared publicationsJ W Choi
2 shared publicationsJ. Choi
Interdisciplinary Program in Biomedical Engineering Major, Graduate School, Seoul National University
2 shared publicationsJ. Chung
Interdisciplinary Program in Biomedical Engineering Major, Graduate School, Seoul National University
2 shared publications- Jun Keun Chang
Seoul National University
2 shared publications
Latest Publications
- 1 May 2008
- Published by Wiley in Artificial Organs
- Vol. 32 (5) , 406-411
Pulse Push/Pull Hemodialysis: In Vitro Study on New Dialysis Modality With Higher Convective Efficiency
Midsize molecule retention is related with renal-failure-associated mortality. Here, the authors describe a new dialysis modality, pulse push/pull hemodialysis (PPPHD), which increases convective clearance. Blood and dialysate are circulated by a pulsatile pump, but with pulsatile flow patterns that are 180 degrees out of phase. This causes blood-to-dialysate pressure gradients that oscillate between positive and negative, and which cause consecutive periods of ultrafiltration and backfiltration. The devised PPPHD was compared with conventional high-flux hemodialysis (CHFHD) in terms of solute clearances, albumin loss, and total protein levels. Human plasma containing dissolved uremic marker molecules was used as a blood substitute, and clearances were investigated for blood urea nitrogen, creatinine, vitamin B12, and inulin. Observed clearances were found to be significantly higher for PPPHD by approximately 3-14% for low-molecular-weight solutes, by 47-48% for vitamin B12, and by 38-49% for inulin than for CHFHD. No albumin loss was observed in either of these two study groups. The authors conclude that PPPHD offers a simple straightforward means of enhancing uremic molecule removal by increasing total ultrafiltration volume without the need to infuse replacement fluid.
- 1 May 2008
- Published by Wiley in Artificial Organs
- Vol. 32 (5) , 406-411
Pulse Push/Pull Hemodialysis: In Vitro Study on New Dialysis Modality With Higher Convective Efficiency
Midsize molecule retention is related with renal-failure-associated mortality. Here, the authors describe a new dialysis modality, pulse push/pull hemodialysis (PPPHD), which increases convective clearance. Blood and dialysate are circulated by a pulsatile pump, but with pulsatile flow patterns that are 180 degrees out of phase. This causes blood-to-dialysate pressure gradients that oscillate between positive and negative, and which cause consecutive periods of ultrafiltration and backfiltration. The devised PPPHD was compared with conventional high-flux hemodialysis (CHFHD) in terms of solute clearances, albumin loss, and total protein levels. Human plasma containing dissolved uremic marker molecules was used as a blood substitute, and clearances were investigated for blood urea nitrogen, creatinine, vitamin B12, and inulin. Observed clearances were found to be significantly higher for PPPHD by approximately 3-14% for low-molecular-weight solutes, by 47-48% for vitamin B12, and by 38-49% for inulin than for CHFHD. No albumin loss was observed in either of these two study groups. The authors conclude that PPPHD offers a simple straightforward means of enhancing uremic molecule removal by increasing total ultrafiltration volume without the need to infuse replacement fluid.
- 15 June 2007
- Published by Wiley in Artificial Organs
- Vol. 31 (8) , 653-658
Convection‐enhanced High‐Flux Hemodialysis
Abstract: Internal filtration contributes to convective clearance in high‐flux hemodialysis but its contribution is limited by low pressure gradients. Therefore, a modification using a conventional dialyzer was conceived to enhance internal filtration and backfiltration (BF) rates. The modified dialyzer includes two longitudinal independent regions for blood flow, which were created by redesigning dialyzer caps. Blood pressures remained higher than dialysate pressures in one region and lower in the other region, allowing continuous internal filtration and BF in these respective regions. Modified and conventional dialyzers were compared in terms of pressure gradients and solute clearances. Thus, our experiments involved two groups: the modified dialyzer group and the conventional dialyzer group. A renal failure model was established using a dog weighing 25–30 kg by renal artery and vein ligation. With the exception of the dialyzers, experimental conditions were identical in the two groups. The pressure gradients between blood and dialysate were much higher for the modified dialyzer than for the conventional dialyzer. No significant differences were observed with respect to small solute clearances between the two groups, but mid‐range solute clearances were significantly higher in the modified group. More optimization is required before the devised unit can be used clinically. However, the devised unit offers a straightforward means of regulating internal filtration and BF rates.
- 15 June 2007
- Published by Wiley in Artificial Organs
- Vol. 31 (8) , 653-658
Convection‐enhanced High‐Flux Hemodialysis
Abstract: Internal filtration contributes to convective clearance in high‐flux hemodialysis but its contribution is limited by low pressure gradients. Therefore, a modification using a conventional dialyzer was conceived to enhance internal filtration and backfiltration (BF) rates. The modified dialyzer includes two longitudinal independent regions for blood flow, which were created by redesigning dialyzer caps. Blood pressures remained higher than dialysate pressures in one region and lower in the other region, allowing continuous internal filtration and BF in these respective regions. Modified and conventional dialyzers were compared in terms of pressure gradients and solute clearances. Thus, our experiments involved two groups: the modified dialyzer group and the conventional dialyzer group. A renal failure model was established using a dog weighing 25–30 kg by renal artery and vein ligation. With the exception of the dialyzers, experimental conditions were identical in the two groups. The pressure gradients between blood and dialysate were much higher for the modified dialyzer than for the conventional dialyzer. No significant differences were observed with respect to small solute clearances between the two groups, but mid‐range solute clearances were significantly higher in the modified group. More optimization is required before the devised unit can be used clinically. However, the devised unit offers a straightforward means of regulating internal filtration and BF rates.
- 30 January 2007
- Published by Springer Nature in Biomedical Microdevices
- Vol. 9 (4) , 435-442
Polymeric nanofiber web-based artificial renal microfluidic chip
In this paper, we present a new method for the creation of a smaller dialyzer and do so by incorporating polymeric nanofiber web, which is known to have good filtration efficiency for broad particle sizes, into a poly (dimethylsiloxane)-based microplatform. We have developed a process that makes possible the efficient production of polyethersulfone and polyurethane nanofiber web and that, itself, incorporates an electrospinning method. We have combined the nanofiber web with the PDMS-based microfluidic platform to create a chip-based portable hemodialysis system. With the dialyzing chip, we evaluated the filtration capability of molecules in broad ranges of sizes and compared the filtration capability of nanofiber membranes with that of PES and polyvinylidene fluoride porous membranes (sheet type): we discovered that the nanofiber membranes have better filtration performance than the other membranes. Blood cells were not mechanically affected during their filtration and their transportation through the chip. In conclusion, we have demonstrated the feasibility of chip-based hemodialysis, and we expect that our method suggested in this paper will be applied to the development of small light-weight dialyzers for the realization of portable hemodialysis systems.
- 30 January 2007
- Published by Springer Nature in Biomedical Microdevices
- Vol. 9 (4) , 435-442
Polymeric nanofiber web-based artificial renal microfluidic chip
In this paper, we present a new method for the creation of a smaller dialyzer and do so by incorporating polymeric nanofiber web, which is known to have good filtration efficiency for broad particle sizes, into a poly (dimethylsiloxane)-based microplatform. We have developed a process that makes possible the efficient production of polyethersulfone and polyurethane nanofiber web and that, itself, incorporates an electrospinning method. We have combined the nanofiber web with the PDMS-based microfluidic platform to create a chip-based portable hemodialysis system. With the dialyzing chip, we evaluated the filtration capability of molecules in broad ranges of sizes and compared the filtration capability of nanofiber membranes with that of PES and polyvinylidene fluoride porous membranes (sheet type): we discovered that the nanofiber membranes have better filtration performance than the other membranes. Blood cells were not mechanically affected during their filtration and their transportation through the chip. In conclusion, we have demonstrated the feasibility of chip-based hemodialysis, and we expect that our method suggested in this paper will be applied to the development of small light-weight dialyzers for the realization of portable hemodialysis systems.
- 1 October 2004
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 27 (10) , 898-903
Home Care Artificial Heart Monitoring System via Internet
The availability of a remote management system, which provides both physiological-related information about the patient and device-related information about the implanted device, would be helpful during in vivo experiments or clinical trials involving artificial heart implantation. In order to be able to monitor the course of the in vivo experiment continuously regardless of the patient's location, an internet-based remote monitoring system was developed, which can monitor physiological-related information such as pressure (AoP, LAP, RAP, PAP) and flow data, as well as device-related information such as current, direction and pump operating conditions. The home care artificial heart monitoring system which we developed consists of four main components, which are the transcutaneous information transmission system (TITS), local monitoring station (LMS), data server station (DSS), and client monitoring station (CMS). The device-related information and physiological-related information can be transmitted in real time from a patient in a remote non-clinical environment to the specialist situated in a clinic depending on the current capabilities and availability of the internet. The local monitoring station situated at the remote site is composed of a data acquisition and preprocessing unit connected to a computer via its RS-232 port, and which communicate using a Java-based client-server architecture. The remote monitoring system so developed was used during an in vivo experiment of the artificial heart implantation for 2 months and performed successfully according to design specifications.
- 1 October 2004
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 27 (10) , 898-903
Home Care Artificial Heart Monitoring System via Internet
The availability of a remote management system, which provides both physiological-related information about the patient and device-related information about the implanted device, would be helpful during in vivo experiments or clinical trials involving artificial heart implantation. In order to be able to monitor the course of the in vivo experiment continuously regardless of the patient's location, an internet-based remote monitoring system was developed, which can monitor physiological-related information such as pressure (AoP, LAP, RAP, PAP) and flow data, as well as device-related information such as current, direction and pump operating conditions. The home care artificial heart monitoring system which we developed consists of four main components, which are the transcutaneous information transmission system (TITS), local monitoring station (LMS), data server station (DSS), and client monitoring station (CMS). The device-related information and physiological-related information can be transmitted in real time from a patient in a remote non-clinical environment to the specialist situated in a clinic depending on the current capabilities and availability of the internet. The local monitoring station situated at the remote site is composed of a data acquisition and preprocessing unit connected to a computer via its RS-232 port, and which communicate using a Java-based client-server architecture. The remote monitoring system so developed was used during an in vivo experiment of the artificial heart implantation for 2 months and performed successfully according to design specifications.
- 1 June 2004
- Published by Wiley in Artificial Organs
- Vol. 28 (6) , 549-555
Assessment and Improvement of the System Efficiency for the Moving-actuator Type Biventricular Assist Device
This is a test report on the efficiency of a moving-actuator type biventricular assist device (AnyHeart, Seoul National University). From the viewpoint of the various system mechanisms, the device can be subdivided into three separate parts: the motor and its associated controller, the actuator and motor assembly, and the blood sac and its associated components (including valves). The motor was operated under various conditions, including different torque, angular speed, and voltage pulses. The total system efficiency of 8% has been reported before, with subpart efficiencies of 50%, 85%, and 19%, respectively, for the motor and its associated controller, the actuator and motor assembly, and the blood sac and its associated components (including valves), under normal operating conditions (4 L/min pump output, 100 mm Hg aortic pressure [AoP]). This article focuses on the method of analyzing and improving the system efficiency. The applied input voltage under the normal operating conditions of the pump was determined using the analyzed results. Also, a speed profile that takes into consideration the filling state of the blood sac was provided. On the basis of tests performed involving in vitro mock circulation, experimental results are provided to demonstrate the effectiveness of the approach presented in this article.
- 1 June 2004
- Published by Wiley in Artificial Organs
- Vol. 28 (6) , 549-555
Assessment and Improvement of the System Efficiency for the Moving-actuator Type Biventricular Assist Device
This is a test report on the efficiency of a moving-actuator type biventricular assist device (AnyHeart, Seoul National University). From the viewpoint of the various system mechanisms, the device can be subdivided into three separate parts: the motor and its associated controller, the actuator and motor assembly, and the blood sac and its associated components (including valves). The motor was operated under various conditions, including different torque, angular speed, and voltage pulses. The total system efficiency of 8% has been reported before, with subpart efficiencies of 50%, 85%, and 19%, respectively, for the motor and its associated controller, the actuator and motor assembly, and the blood sac and its associated components (including valves), under normal operating conditions (4 L/min pump output, 100 mm Hg aortic pressure [AoP]). This article focuses on the method of analyzing and improving the system efficiency. The applied input voltage under the normal operating conditions of the pump was determined using the analyzed results. Also, a speed profile that takes into consideration the filling state of the blood sac was provided. On the basis of tests performed involving in vitro mock circulation, experimental results are provided to demonstrate the effectiveness of the approach presented in this article.
- 20 November 2003
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 59-61
Development of an online database system for remote monitoring of artificial heart patient
An online database system for remote monitoring of artificial heart patient has been developed. It is important for the patient with artificial heart implant to be discharged from the hospital after proper stabilization period for better and fast recovery and quality of life. The patients with artificial heart or mechanical circulatory support device are currently discharged after 1-2 months of hospitalization period. But, reliable and practical continuous remote monitoring systems for this kind of patients with life support device are still under study. The authors have developed a database system for this purpose that consists of a portable monitoring terminal, a database for continuous recording of patient and device status, and a web-based data access system with which the clinicians can access the real-time registering of patient data and past history data as well. The system has been tested with data generation emulators installed on remote sites for simulation study and in 2 cases of actual animal experiment conducted at remote facilities. The system showed acceptable functionality and reliability. The results are expected to be a good base for practical use of the system. A machine intelligence based automatic data analysis module is to be included for better practicality.
- 20 November 2003
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 59-61
Development of an online database system for remote monitoring of artificial heart patient
An online database system for remote monitoring of artificial heart patient has been developed. It is important for the patient with artificial heart implant to be discharged from the hospital after proper stabilization period for better and fast recovery and quality of life. The patients with artificial heart or mechanical circulatory support device are currently discharged after 1-2 months of hospitalization period. But, reliable and practical continuous remote monitoring systems for this kind of patients with life support device are still under study. The authors have developed a database system for this purpose that consists of a portable monitoring terminal, a database for continuous recording of patient and device status, and a web-based data access system with which the clinicians can access the real-time registering of patient data and past history data as well. The system has been tested with data generation emulators installed on remote sites for simulation study and in 2 cases of actual animal experiment conducted at remote facilities. The system showed acceptable functionality and reliability. The results are expected to be a good base for practical use of the system. A machine intelligence based automatic data analysis module is to be included for better practicality.
- 1 January 2003
- Published by Wiley in Artificial Organs
- Vol. 27 (1) , 119-123
Development of Totally Implantable Pulsatile Biventricular Assist Device
- 1 January 2003
- Published by Wiley in Artificial Organs
- Vol. 27 (1) , 119-123
Development of Totally Implantable Pulsatile Biventricular Assist Device
- 1 December 2002
- Vol. 43 (6) , 891-4
In vivo evaluation of lumbrokinase, a fibrinolytic enzyme extracted from Lumbricus rubellus, in a prosthetic vascular graft.
Lumbrokinase (LK) is a fibrinolytic enzyme purified from the earthworm Lumbricus rubellus. To investigate the fibrinolytic and antithrombotic effects of lumbrokinase, a series of animal experiments were performed. The Dacron graft (3 mm in diameter, 3 cm in length) were treated with LK via two different methods, simple dipping and covalent bonding Covalent bonding was performed by UV reaction to polyacrylic acid. The grafts were interposed into the inferior vena cava of the rabbits and harvested for 5 hours, 1, 2 and 4 weeks after the implantation. The LK non-treated graft (n=4) were totally occluded with thrombus 5 hours after the implantation. Both types of LK treated graft (n=8) were patent 1 week after the implantation. The grafts treated with the simple dipping method (n=4) were occluded with thrombus 2 weeks after the implantation. The grafts treated with covalent bonding (n=4) were patent 4 weeks after the implantation. Ultrastructural analysis of the luminal surface of the patent grafts by scanning electron microscopy revealed the thin plasma protein layer to be about 5 micro in thickness with platelet adhesions. Lumbrokinase has potential antithrombotic effects in a small diameter vascular prosthesis. The covalent bonding method proved to be more effective than the simple dipping method.
- 1 December 2002
- Vol. 43 (6) , 891-4
In vivo evaluation of lumbrokinase, a fibrinolytic enzyme extracted from Lumbricus rubellus, in a prosthetic vascular graft.
Lumbrokinase (LK) is a fibrinolytic enzyme purified from the earthworm Lumbricus rubellus. To investigate the fibrinolytic and antithrombotic effects of lumbrokinase, a series of animal experiments were performed. The Dacron graft (3 mm in diameter, 3 cm in length) were treated with LK via two different methods, simple dipping and covalent bonding Covalent bonding was performed by UV reaction to polyacrylic acid. The grafts were interposed into the inferior vena cava of the rabbits and harvested for 5 hours, 1, 2 and 4 weeks after the implantation. The LK non-treated graft (n=4) were totally occluded with thrombus 5 hours after the implantation. Both types of LK treated graft (n=8) were patent 1 week after the implantation. The grafts treated with the simple dipping method (n=4) were occluded with thrombus 2 weeks after the implantation. The grafts treated with covalent bonding (n=4) were patent 4 weeks after the implantation. Ultrastructural analysis of the luminal surface of the patent grafts by scanning electron microscopy revealed the thin plasma protein layer to be about 5 micro in thickness with platelet adhesions. Lumbrokinase has potential antithrombotic effects in a small diameter vascular prosthesis. The covalent bonding method proved to be more effective than the simple dipping method.
- 1 September 2002
- Published by Springer Nature in Journal of Artificial Organs
- Vol. 5 (3) , 147-148
The total artificial heart and implantable biventricular assist device
- 1 September 2002
- Published by Springer Nature in Journal of Artificial Organs
- Vol. 5 (3) , 147-148
The total artificial heart and implantable biventricular assist device
- 1 September 1997
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 43 (5) , M592-92
Intelligent Li Ion Battery Management Based on a Digital Signal Processor for a Moving Actuator Total Artificial Heart
An intelligent Li Ion battery management (ILBM) system was developed based on a digital signal processor (DSP). Instead of using relatively complicated hardware charging control, a DSP algorithm was used, and favorable characteristics in volume, mass, and temperature increase of the implantable battery were achieved. In vitro tests were performed to evaluate the DSP based algorithm for Li Ion charging control (24 V dc motor input power 16 W, 5 L/min, 100 mmHg afterload). In this article, the first improvement was volume reduction using a Li Ion battery (3.6 V/Cell, 900 mA, seven cells: 25.2 V, 22.7 W). Its volume and mass were decreased by 40% and 50% respectively (40*55*75 mm, 189 g), compared to previously reported results, with total energy capacity increased by 110% (more than 60 min vs 25 min run time in the other battery). The second improvement includes the ILBM, which can control the performance detection for each unit cell and has a low temperature rise. The ILBM's unit cell energy detection was important because the low performance of one cell dropped to 50% of the total performance along with a 20% increase in surface temperature. All electronics for a transcutaneous energy transmission (TET), battery, and telemetry were finalized for hybridization and used for total artificial heart (TAH) implantation. ASAIO Journal 1997; 43:M588-M592.
- 1 September 1997
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 43 (5) , M592-92
Intelligent Li Ion Battery Management Based on a Digital Signal Processor for a Moving Actuator Total Artificial Heart
An intelligent Li Ion battery management (ILBM) system was developed based on a digital signal processor (DSP). Instead of using relatively complicated hardware charging control, a DSP algorithm was used, and favorable characteristics in volume, mass, and temperature increase of the implantable battery were achieved. In vitro tests were performed to evaluate the DSP based algorithm for Li Ion charging control (24 V dc motor input power 16 W, 5 L/min, 100 mmHg afterload). In this article, the first improvement was volume reduction using a Li Ion battery (3.6 V/Cell, 900 mA, seven cells: 25.2 V, 22.7 W). Its volume and mass were decreased by 40% and 50% respectively (40*55*75 mm, 189 g), compared to previously reported results, with total energy capacity increased by 110% (more than 60 min vs 25 min run time in the other battery). The second improvement includes the ILBM, which can control the performance detection for each unit cell and has a low temperature rise. The ILBM's unit cell energy detection was important because the low performance of one cell dropped to 50% of the total performance along with a 20% increase in surface temperature. All electronics for a transcutaneous energy transmission (TET), battery, and telemetry were finalized for hybridization and used for total artificial heart (TAH) implantation. ASAIO Journal 1997; 43:M588-M592.